Neoantigenics
Charlottesville, US · Founded 2012 · Delaware corporation · 1 known investors
Founders & leadership
Neoantigenics was founded in 2012 by John C. Herr.
JC
John C. HerrFounder
EJ
Edward J. LearyExecutive
BA
Brian A. PollokExecutive
Board
FE
Investors · 1
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2015
▶$3MraisedFeb 2015 · 4 investors · BiotechnologyRule 506(b)
▶$3MraisedFeb 2015 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Edward J. LearyExecutive Officer, Promoter
- Brian A. PollokExecutive Officer, Director, Promoter
- John C. HerrExecutive Officer, Director, Promoter
- Fred EshelmanDirector
- Offering amount
- $3M
- Amount sold
- $3M
- Proceeds to insiders
- $370K
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Neoantigenics?
- Neoantigenics was founded by John C. Herr in 2012.
- Who are Neoantigenics's investors?
- Neoantigenics's investors include Eshelman Ventures, LLC.
- How much funding has Neoantigenics raised?
- Neoantigenics has disclosed $3M raised across 1 round.
- Where is Neoantigenics headquartered?
- Neoantigenics is headquartered in Charlottesville, US.